Cytisine eye drops for benzalkonium chloride-induced dry eye: safety and efficacy evaluation

References

• Alfarisi O, Mave V, Gaikwad S, Sahasrabudhe T, Ramachandran G, Kumar H, Gupte N, Kulkarni V, Deshmukh S, Atre S, et al. 2018. Effect of diabetes mellitus on the pharmacokinetics and pharmacodynamics of tuberculosis treatment. Antimicrob Agents Chemother. 62(11):e01383–e01418. doi: 10.1128/AAC.01383-18.
   PubMed Web of Science ®Google Scholar
• Amanat S, Shal B, Kyoung Seo E, Ali H, Khan S. 2022. Icariin attenuates cyclophosphamide-induced cystitis via down-regulation of NF-кB and up-regulation of Nrf-2/HO-1 signaling pathways in mice model. Int Immunopharmacol. 106:108604. doi: 10.1016/j.intimp.2022.108604.
   PubMed Web of Science ®Google Scholar
• Barabino S, Chen Y, Chauhan S, Dana R. 2012. Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease. Prog Retin Eye Res. 31(3):271–285. doi: 10.1016/j.preteyeres.2012.02.003.
   PubMed Web of Science ®Google Scholar
• Bashrahil B, Taher N, Alzahrani Z, Alnabihi A, Aldahlawi A, Alkhathlan M, Alghamdi S. 2023. The efficacy and safety of varenicline nasal spray for the management of dry eye signs: a systematic review and meta-analysis. BMC Ophthalmol. 23(1):319. doi: 10.1186/s12886-023-03069-y.
   PubMed Web of Science ®Google Scholar
• Condon PI, McEwen CG, Wright M, Mackintosh G, Prescott RJ, McDonald C. 1999. Double blind, randomised, placebo controlled, crossover, multicentre study to determine the efficacy of a 0.1% (w/v) sodium hyaluronate solution (Fermavisc) in the treatment of dry eye syndrome. Br J Ophthalmol. 83(10):1121–1124. doi: 10.1136/bjo.83.10.1121.
   PubMed Web of Science ®Google Scholar
• Contreras-Ruiz L, Zorzi GK, Hileeto D, López-García A, Calonge M, Seijo B, Sánchez A, Diebold Y. 2013. A nanomedicine to treat ocular surface inflammation: performance on an experimental dry eye murine model. Gene Ther. 20(5):467–477. doi: 10.1038/gt.2012.56.
   PubMed Web of Science ®Google Scholar
• de Oliveira FA, Albuquerque LJC, Nascimento-Sales M, Christoffolete MA, Bellettini IC, Giacomelli FC. 2023. Balancing gene transfection and cytotoxicity of nucleic acid carriers with focus on ocular and hepatic disorders: evaluation of hydrophobic and hydrophilic polyethyleneimine derivatives. J Mater Chem B. 11(20):4556–4571. doi: 10.1039/d3tb00477e.
   PubMed Web of Science ®Google Scholar
• Di Tommaso C, Torriglia A, Furrer P, Behar-Cohen F, Gurny R, Möller M. 2011. Ocular biocompatibility of novel Cyclosporin A formulations based on methoxy poly(ethylene glycol)-hexylsubstituted poly(lactide) micelle carriers. Int J Pharm. 416(2):515–524. doi: 10.1016/j.ijpharm.2011.01.004.
   PubMed Web of Science ®Google Scholar
• Dogru M, Kojima T, Simsek C, Tsubota K. 2018. Potential role of oxidative stress in ocular surface inflammation and dry eye disease. Invest Ophthalmol Vis Sci. 59(14):Des163–des168. doi: 10.1167/iovs.17-23402.
   PubMed Web of Science ®Google Scholar
• Elmowafy E, Gad H, Biondo F, Casettari L, Soliman ME. 2019. Exploring optimized methoxy poly(ethylene glycol)-block-poly(ε-caprolactone) crystalline cored micelles in anti-glaucoma pharmacotherapy. Int J Pharm. 566:573–584. doi: 10.1016/j.ijpharm.2019.06.011.
   PubMedGoogle Scholar
• Etter J-F, Lukas RJ, Benowitz NL, West R, Dresler CM. 2008. Cytisine for smoking cessation: a research agenda. Drug Alcohol Depend. 92(1-3):3–8. doi: 10.1016/j.drugalcdep.2007.06.017.
   PubMed Web of Science ®Google Scholar
• Fakih D, Zhao Z, Nicolle P, Reboussin E, Joubert F, Luzu J, Labbé A, Rostène W, Baudouin C, Mélik Parsadaniantz S, et al. 2019. Chronic dry eye induced corneal hypersensitivity, neuroinflammatory responses, and synaptic plasticity in the mouse trigeminal brainstem. J Neuroinflammation. 16(1):268. doi: 10.1186/s12974-019-1656-4.
   PubMed Web of Science ®Google Scholar
• Gedar Totuk OM, Yildiz E, Mollica A, Kabadayi K, Sahin A. 2021. The opioid peptide biphalin modulates human corneal epithelial wound healing in vitro. J Fr Ophtalmol. 44(9):1403–1412. doi: 10.1016/j.jfo.2020.09.007.
   PubMed Web of Science ®Google Scholar
• Goldstein MH, Silva FQ, Blender N, Tran T, Vantipalli S. 2022. Ocular benzalkonium chloride exposure: problems and solutions. Eye. 36(2):361–368. doi: 10.1038/s41433-021-01668-x.
   PubMed Web of Science ®Google Scholar
• He R, Cui M, Lin H, Zhao L, Wang J, Chen S, Shao Z. 2018. Melatonin resists oxidative stress-induced apoptosis in nucleus pulposus cells. Life Sci. 199:122–130. doi: 10.1016/j.lfs.2018.03.020.
   PubMed Web of Science ®Google Scholar
• Holland EJ, Luchs J, Karpecki PM, Nichols KK, Jackson MA, Sall K, Tauber J, Roy M, Raychaudhuri A, Shojaei A. 2017. Lifitegrast for the treatment of dry eye disease: results of a phase III, randomized, double-masked, placebo-controlled trial (OPUS-3). Ophthalmology. 124(1):53–60. doi: 10.1016/j.ophtha.2016.09.025.
   PubMed Web of Science ®Google Scholar
• Hou Y, Lan J, Zhang F, Wu X. 2021. Expression profiles and potential corneal epithelial wound healing regulation targets of high-mobility group box 1 in diabetic mice. Exp Eye Res. 202:108364. doi: 10.1016/j.exer.2020.108364.
   PubMed Web of Science ®Google Scholar
• Hussar DA, Finn LA. 2017. 2017 new drug update. Consult Pharm. 32(5):258–268. doi: 10.4140/TCP.n.2017.258.
   PubMedGoogle Scholar
• Hynnekleiv L, Magno M, Vernhardsdottir RR, Moschowits E, Tønseth KA, Dartt DA, Vehof J, Utheim TP. 2022. Hyaluronic acid in the treatment of dry eye disease. Acta Ophthalmol. 100(8):844–860. doi: 10.1111/aos.15159.
   PubMed Web of Science ®Google Scholar
• Lagarto A, Vega R, Guerra I, González R. 2006. In vitro quantitative determination of ophthalmic irritancy by the chorioallantoic membrane test with trypan blue staining as alternative to eye irritation test. Toxicol in Vitro. 20(5):699–702. doi: 10.1016/j.tiv.2005.10.003.
   PubMed Web of Science ®Google Scholar
• Li Q, Wu X, Xin S, Wu X, Lan J. 2021. Preparation and characterization of a naringenin solubilizing glycyrrhizin nanomicelle ophthalmic solution for experimental dry eye disease. Eur J Pharm Sci. 167:106020. doi: 10.1016/j.ejps.2021.106020.
   PubMed Web of Science ®Google Scholar
• Li Y, Guan Q, Xu J, Zhang H, Liu S, Ding Z, Wang Q, Wang Z, Liu M, Zhao Y. 2023. Comparative study of cyclosporine A liposomes and emulsions for ophthalmic drug delivery: process optimization through response surface methodology (RSM) and biocompatibility evaluation. Colloids Surf B Biointerfaces. 225:113267. doi: 10.1016/j.colsurfb.2023.113267.
   PubMed Web of Science ®Google Scholar
• Liang Q, Guo R, Tsao JR, He Y, Wang C, Jiang J, Zhang D, Chen T, Yue T, Hu K. 2023. Salidroside alleviates oxidative stress in dry eye disease by activating autophagy through AMPK-Sirt1 pathway. Int Immunopharmacol. 121:110397. doi: 10.1016/j.intimp.2023.110397.
   PubMed Web of Science ®Google Scholar
• Messmer EM. 2015. The pathophysiology, diagnosis, and treatment of dry eye disease. Dtsch Arztebl Int. 112(5):71–81; quiz 82. doi: 10.3238/arztebl.2015.0071.
   PubMed Web of Science ®Google Scholar
• Mohamed HB, Abd El-Hamid BN, Fathalla D, Fouad EA. 2022. Current trends in pharmaceutical treatment of dry eye disease: a review. Eur J Pharm Sci. 175:106206. doi: 10.1016/j.ejps.2022.106206.
   PubMed Web of Science ®Google Scholar
• Na YJ, Choi KJ, Jung WH, Park SB, Kang S, Ahn JH, Kim KY. 2020. A Novel Selective 11β-HSD1 Inhibitor, (E)-4-(2-(6-(2,6-Dichloro-4-(Trifluoromethyl)Phenyl)-4-Methyl-1,1-Dioxido-1,2,6-Thiadiazinan-2-yl)Acetamido)Adamantan-1-Carboxamide (KR-67607), Prevents BAC-Induced Dry Eye Syndrome. Int J Mol Sci. 21(10):3729. doi: 10.3390/ijms21103729.
   PubMed Web of Science ®Google Scholar
• Okmanov RY, Olimova MI, Karabaeva SB, Sapaev FA, Abdireymov KB, Weil M. 2023. Syntheses, crystal structures and Hirshfeld surface analyses of N-aryl­sulfonyl derivatives of cytisine. Acta Crystallogr E Crystallogr Commun. 79(Pt 4):313–318. doi: 10.1107/S2056989023001950.
   PubMedGoogle Scholar
• Padjasek M, Qasem B, Cisło-Pakuluk A, Marycz K. 2022. Cyclosporine A delivery platform for veterinary ophthalmology-A new concept for advanced ophthalmology. Biomolecules. 12(10):1525. doi: 10.3390/biom12101525.
   PubMed Web of Science ®Google Scholar
• Park B, Lee IS, Hyun SW, Jo K, Lee TG, Kim JS, Kim CS. 2018. The protective effect of Polygonum cuspidatum (PCE) aqueous extract in a dry eye model. Nutrients. 10(10):1550. doi: 10.3390/nu10101550.
   PubMed Web of Science ®Google Scholar
• Saccà SC, Cutolo CA, Ferrari D, Corazza P, Traverso CE. 2018. The eye, oxidative damage and polyunsaturated fatty acids. Nutrients. 10(6):668. doi: 10.3390/nu10060668.
   PubMed Web of Science ®Google Scholar
• Srinivasan S, Garofalo R, Williams R. 2023. Safe and effective management of dry eye symptoms with hydroxypropyl guar and hyaluronic acid dual-polymer lubricating eye drops: a review of preclinical and clinical studies. Clin Ophthalmol. 17:3883–3898. doi: 10.2147/OPTH.S428725.
   PubMed Web of Science ®Google Scholar
• Suri R, Neupane YR, Mehra N, Nematullah M, Khan F, Alam O, Iqubal A, Jain GK, Kohli K. 2021. Sirolimus loaded chitosan functionalized poly (lactic-co-glycolic acid) (PLGA) nanoparticles for potential treatment of age-related macular degeneration. Int J Biol Macromol. 191:548–559. doi: 10.1016/j.ijbiomac.2021.09.069.
   PubMed Web of Science ®Google Scholar
• Wang S, He X, Li Q, Zhang Y, Hu J, Zong R, Zhuang J, Quantock AJ, Gao Y, Li W, et al. 2022. Obstructive sleep apnea affects lacrimal gland function. Invest Ophthalmol Vis Sci. 63(3):3. doi: 10.1167/iovs.63.3.3.
   Web of Science ®Google Scholar
• Wang TZ, Guan B, Liu XX, Ke LN, Wang JJ, Nan KH. 2022. A topical fluorometholone nanoformulation fabricated under aqueous condition for the treatment of dry eye. Colloids Surf B Biointerfaces. 212:112351. doi: 10.1016/j.colsurfb.2022.112351.
   PubMed Web of Science ®Google Scholar
• Wu L, Ye M, Zhang J. 2018. Vincamine prevents lipopolysaccharide induced inflammation and oxidative stress via thioredoxin reductase activation in human corneal epithelial cells. Am J Transl Res. 10(7):2195–2204.
   PubMed Web of Science ®Google Scholar
• Zhang R, Yang J, Luo Q, Shi J, Xu H, Zhang J. 2022. Preparation and in vitro and in vivo evaluation of an isoliquiritigenin-loaded ophthalmic nanoemulsion for the treatment of corneal neovascularization. Drug Deliv. 29(1):2217–2233. doi: 10.1080/10717544.2022.2096714.
   PubMed Web of Science ®Google Scholar
• Zhou T, Zong R, Zhang Z, Zhu C, Pan F, Xiao X, Liu Z, He H, Ma JX, Liu Z, et al. 2012. SERPINA3K protects against oxidative stress via modulating ROS generation/degradation and KEAP1-NRF2 pathway in the corneal epithelium. Invest Ophthalmol Vis Sci. 53(8):5033–5043. doi: 10.1167/iovs.12-9729.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Li XY, Wang J, Zhu YG. 2019. Bradykinin alleviates DR retinal endothelial injury by regulating HMGB-1/NF-κB pathway. Eur Rev Med Pharmacol Sci. 23:5535–5541.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Peng X, Zhang Y, Lin J, Zhao G. 2021. Baicalein protects against aspergillus fumigatus keratitis by reducing fungal load and inhibiting TSLP-induced inflammatory response. Invest Ophthalmol Vis Sci. 62(6):26. doi: 10.1167/iovs.62.6.26.
   PubMed Web of Science ®Google Scholar